SLC28A1 and pancreatic neoplasm: Our findings demonstrate that the oncomiRs, miR-106a and miR-17, regulate expression of the nucleoside transporter hCNT1 in colorectal and pancreatic cancer and thereby contribute to chemoresistance to fluoropyrimidine-based treatments.